| cisplatin / Generic mfg. |
NCT00002615: Surgery With or Without Combination Chemotherapy in Treating Patients With Stomach Cancer |
|
|
| Completed | 3 | 500 | Europe | cisplatin, epirubicin hydrochloride, fluorouracil, conventional surgery | Medical Research Council | Gastric Cancer | | 12/03 | | |
NCT00004099: Surgery With or Without Combination Chemotherapy in Treating Patients With Stomach Cancer |
|
|
| Terminated | 3 | 144 | Europe, RoW | cisplatin, fluorouracil, leucovorin calcium, neoadjuvant therapy | European Organisation for Research and Treatment of Cancer - EORTC | Gastric Cancer | 02/04 | | | |
| Completed | 3 | 240 | Europe | Taxotere-Cisplatin-5FU, Immediate surgery | Swiss Group for Clinical Cancer Research | Gastric Cancer | 11/05 | 03/06 | | |
NCT00150670: Randomized Phase III Study of TS-1 Alone Versus TS-1 Plus CDDP in Advanced Gastric Cancer |
|
|
| Completed | 3 | 300 | Japan | TS-1 and cisplatin, TS-1 | Taiho Pharmaceutical Co., Ltd. | Gastric Cancer | 12/06 | 12/06 | | |
| Completed | 3 | 690 | Japan | continuous infusion of 5-fluorouracil, combination of irinotecan and cisplatin, oral administration of S-1 | Japan Clinical Oncology Group, Ministry of Health, Labour and Welfare, Japan, Taiho Pharmaceutical Co., Ltd., Yakult Honsha Co., LTD | Gastric Cancer | | 01/07 | | |
NCT00296335: Trial of Adjuvant Chemotherapy for Gastric Cancer |
|
|
| Completed | 3 | 855 | RoW | Mitomycin, doxifluridine and cisplatin, Mitomycin and doxifluridine | Asan Medical Center, Ulsan University Hospital, Hallym University Medical Center | Stomach Cancer | 11/07 | 12/09 | | |
NCT00323830: Phase III Randomized Trial of Adjuvant XP Chemotherapy and XP/RT for Resected Gastric Adenocarcinoma |
|
|
| Completed | 3 | 458 | RoW | Capecitabine, cisplatin, Radiotherapy (+/-) | Samsung Medical Center | Gastric Cancer, Surgery | 04/08 | 04/11 | | |
NCT00182611: S-1 and Cisplatin in Treating Patients Who Are Undergoing Surgery for Stage III Stomach Cancer |
|
|
| Completed | 3 | 100 | Japan | cisplatin, tegafur-gimeracil-oteracil potassium, adjuvant therapy, conventional surgery, neoadjuvant therapy | Kyoto University | Gastric Cancer | 09/08 | 11/08 | | |
NCT00313872: Phase III Trial of DP Followed by FOLFIRI or the Reverse Sequence in Unresectable Gastric Cancer |
|
|
| Completed | 3 | 200 | RoW | DP, FOLFIRI | Samsung Medical Center | Gastric Cancer, Metastases | 06/09 | 01/10 | | |
AVAGAST, NCT00548548: A Study of Bevacizumab in Combination With Capecitabine and Cisplatin as First-line Therapy in Patients With Advanced Gastric Cancer |
|
|
| Completed | 3 | 774 | US | Bevacizumab, Capecitabine, Cisplatin, Placebo, 5-fluorouracil | Genentech, Inc., Hoffmann-La Roche, Chugai Pharmaceutical | Adenocarcinoma | 11/09 | 11/13 | | |
|
|
|
|
|
|
GASTRANOX, NCT00718354: Overall Survival of Inoperable Gastric/GastroOesophageal Cancer Subjects on Treating With LMWH + Chemotherapy(CT) vs Standard CT |
|
|
| Completed | 3 | 740 | RoW | Enoxaparin, Standard Chemotherapy, Some commonly prescribed Chemotherapy regimens in India are:, - Epirubicin + Cisplatin + Capecitabine, - Capecitabine + Oxaliplatin, - Docetaxil + Carboplatin, - Epirubicin + Cisplatin + Fluorouracil, - Docetaxil + Cisplatin with G/C/S/F support, - Epirubicin + Cisplatin + Flourouracil, - Docetaxil + Cisplatin + Flourouracil | Thrombosis Research Institute | Gastric Cancer, Gastroesophageal Cancer | 01/10 | 08/10 | | |
ToGA, NCT01041404 / 2005-000387-39: Study - A Study of Herceptin (Trastuzumab) in Combination With Chemotherapy Compared With Chemotherapy Alone in Patients With HER2-Positive Advanced Gastric Cancer |
|
|
| Completed | 3 | 584 | Japan, Europe, RoW | Trastuzumab, Herceptin, Fluorouracil, 5-FU, Cisplatin, Capecitabine, Xeloda | Hoffmann-La Roche, Chugai Pharmaceutical | Gastric Cancer | 06/10 | 06/10 | | |
|
|
|
|
NCT00887822: A Study of Bevacizumab (Avastin) Versus Placebo in Combination With Capecitabine (Xeloda) and Cisplatin as First-Line Therapy for Advanced Gastric Cancer |
|
|
| Completed | 3 | 202 | RoW | Bevacizumab, Avastin, Placebo, Capecitabine, Xeloda, Cisplatin | Hoffmann-La Roche | Gastric Cancer | 05/11 | 08/14 | | |
|
NCT00123318: A Feasibility Study to Evaluate Adjuvant Chemoradiotherapy for Gastric Cancer |
|
|
| Completed | 3 | 52 | RoW | epirubicin, Epirubicin Ebewe, Epirubicin Hydrochloride for Injection, cisplatin, Cisplatin Ebewe, Cisplatin Injection, 5-fluorouracil, DBL Fluoruracil Injection BP, Efudix, Radiotherapy, Radiation | Trans Tasman Radiation Oncology Group, The Royal Australian and New Zealand College of Radiologists | Gastric Cancer | 02/12 | 02/12 | | |
| Completed | 3 | 904 | Japan, Europe, RoW | Cetuximab, Erbitux, Capecitabine, Xeloda, Cisplatin | Merck KGaA, Darmstadt, Germany | Gastric Cancer | 03/12 | 02/13 | | |
|
|
NCT00811447: Taxotere New Indication - Gastric Cancer Treatment Registration Trial |
|
|
| Completed | 3 | 243 | RoW | 5-fluorouracil, Cisplatin, Docetaxel | Sanofi | Stomach Neoplasms | 06/12 | 06/12 | | |
SOPP, NCT01671449: S-1 and Cisplatin (3 Weekly) Versus S-1 and Oxaliplatin Combination Chemotherapy for Advanced Gastric Cancer |
|
|
| Completed | 3 | 338 | RoW | S-1, TS-1, Cisplatin, Oxaliplatin, Pleoxin | Min-Hee Ryu | Gastric Cancer | 10/14 | 10/15 | | |
RILOMET-1, NCT01697072 / 2011-004923-11: First-Line Treatment for Locally Advanced or Metastatic Mesenchymal Epithelial Transition Factor (MET) - Positive Gastric, Lower Esophageal, or Gastroesophageal Junction (GEJ) Adenocarcinoma |
|
|
| Terminated | 3 | 609 | US, Canada, Europe, RoW | Rilotumumab, AMG102, Placebo, sterile protein-free solution, Epirubicin, Ellence, Pharmorubicin PFS, Pharmorubicin RDF, Cisplatin, Platinol, Platinol-AQ, Capecitabine, Xeloda | Amgen | Gastric Cancer | 11/14 | 08/15 | | |
|
|
NCT01450696 / 2011-001526-19: A Study of Herceptin (Trastuzumab) in Combination With Cisplatin/Capecitabine Chemotherapy in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Gastric or Gastro-Esophageal Junction Cancer |
|
|
| Terminated | 3 | 296 | US, Europe, RoW | Capecitabine, Cisplatin, Herceptin, Trastuzumab | Hoffmann-La Roche | Gastric Cancer | 02/15 | 08/15 | | |
| Completed | 3 | 316 | Japan | Gastrectomy with more than D2 dissection, Neoadjuvant chemotherapy(TS-1+CDDP) followed by gastrectomy | Haruhiko Fukuda, Ministry of Health, Labour and Welfare, Japan | Gastric Neoplasm | 04/15 | 04/15 | | |
RILOMET-2, NCT02137343: A Phase 3 Study of Rilotumumab (AMG 102) With Cisplatin and Capecitabine (CX) as First-line Therapy in Gastric Cancer |
|
|
| Terminated | 3 | 34 | Japan, RoW | Rilotumumab, AMG102, Placebo, Cisplatin, Platinol, Platinal-AQ, Capecitabine, Xeloda | Amgen | Gastric Cancer | 06/15 | 06/15 | | |
|
| Active, not recruiting | 3 | 788 | Europe | cisplatin+capecitabine, radiotherapy, epirubicin+cisplatin+capecitabine | Dutch Colorectal Cancer Group, The Netherlands Cancer Institute, Roche Pharma AG | Gastric Cancer | 12/18 | 12/25 | | |
NCT01824459: S-1+Oxaliplatin vs.S-1+Cisplatin First-line Treatment of Advanced or Recurrent Non-intestinal Type Gastric Adenocarcinoma Patients |
|
|
| Completed | 3 | 576 | RoW | S-1, Oxaliplatin, Cisplatin | Sun Yat-sen University, Taiho Pharmaceutical Co., Ltd. | Gastric Cancer | 12/18 | 12/18 | | |
NCT00290966: Randomized Multicenter Study Comparing Docetaxel Plus Cisplatin and 5-FU to Cisplatin Plus 5-FU in Advanced Gastric Cancer |
|
|
| Completed | 2/3 | 610 | US, RoW | XRP6976 | Sanofi | Stomach Neoplasm | | 05/03 | | |
| Terminated | 2/3 | 3 | Europe | positive cytology with HIPEC, mytomycin and cisplatin | University Hospital Tuebingen | Gastric Cancer, Peritoneal Carcinomatosis | 05/15 | 05/15 | | |
